Početna › Melanom › Washington › Seattle
Kliničke studije za Melanom u gradu Seattle, WA
17 studija za Melanom traži sudionike na lokacijama u gradu Seattle i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- i još 1
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
U tijeku regrutacijaFaza 2
- Fred Hutchinson Cancer Center ( Site 4041), Seattle
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
U tijeku regrutacijaFaza 3
- Swedish Cancer Institute, Seattle
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
U tijeku regrutacijaFaza 3
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center - Montlake, Seattle
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 mi udaljenosti
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
U tijeku regrutacijaFaza 1/2
- University of Washington Fred Hutchinson Cancer Center, Seattle
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
U tijeku regrutacijaFaza 2
- Local Institution - 0086, Seattle
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
U tijeku regrutacijaFaza 2
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
Project: Every Child for Younger Patients With Cancer
U tijeku regrutacijaOpažajna studija
- Seattle Children's Hospital, Seattle
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
U tijeku regrutacija
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
U tijeku regrutacijaFaza 1
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
U tijeku regrutacijaFaza 1/2
- Virginia Mason Medical Center, Seattle
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
U tijeku regrutacijaFaza 1/2
- Fred Hutchinson Cancer Center, Seattle
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
U tijeku regrutacijaFaza 2/3
- Fred Hutchinson Cancer Center, Seattle
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
U tijeku regrutacijaOpažajna studija
- Kaiser Permanente Washington, Seattle
- Swedish Medical Center-First Hill, Seattle
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
U tijeku regrutacijaFaza 3
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
U tijeku regrutacijaOpažajna studija
- Massive Bio SYNERGY-AI site, Seattle
A Study of IBI363 in Subjects with Advanced Solid Malignancies
U tijeku regrutacijaFaza 2
- Fred Hutchinson Cancer Center, Seattle
Studije za Melanom u drugim gradovima
- Houston, TX59 studija
- New York City, NY38 studija
- Los Angeles, CA34 studija
- Nashville, TN33 studija
- Pittsburgh, PA31 studija
- Boston, MA26 studija
- Philadelphia, PA23 studija
- San Francisco, CA22 studija
- Durham, NC21 studija
- Atlanta, GA21 studija
- St. Louis, MO21 studija
- Salt Lake City, UT21 studija
Ostale studije u gradu Seattle
- Nemikrocelularni karcinom pluća53 studija
- Rak (sve vrste)49 studija
- Rak prostate42 studija
- Akutna mijeloična leukemija40 studija
- Rak dojke39 studija
- Metastatski karcinom39 studija
- Kolorektalni rak34 studija
- Rak pluća33 studija
- Rak jajnika30 studija
- Multipli mijelom22 studija
- Mijelodisplastični sindromi21 studija
- Akutna limfoblastna leukemija21 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.